<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9615">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05694299</url>
  </required_header>
  <id_info>
    <org_study_id>2021_67</org_study_id>
    <secondary_id>210808 (FIXIT)</secondary_id>
    <nct_id>NCT05694299</nct_id>
  </id_info>
  <brief_title>Nasal Bridle Versus Nasal Patch for Fixation of Nasoenteral Feeding Tubes</brief_title>
  <acronym>FIXIT</acronym>
  <official_title>Nasal Bridle Versus Nasal Patch for Fixation of Nasoenteral Feeding Tubes: a Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gelre Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medisch Spectrum Twente</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gelre Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study is to compare fixation of nasoenteral feeding tubes using either a nasal&#xD;
      patch or a nasal bridle in clinical patients with regard to the occurrence of tube&#xD;
      dislocation, complications, and discomfort. 78 (2 * 39) eligible patients will be included in&#xD;
      this randomized controlled trial. The study is executed in two general teaching hospitals in&#xD;
      the Netherlands (Gelre Hospitals Apeldoorn and Medical Spectrum Twente).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>The data analist who will perform the statistical analyses (TS) will be masked (i.e., will analyze groups labelled as 'A' and 'B').</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Premature dislocation of feeding tube</measure>
    <time_frame>Within 14 days after initial placement of the feeding tube</time_frame>
    <description>Occurrence of a first premature dislocation of the feeding tube</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications related to fixation of the feeding tube</measure>
    <time_frame>During the 14-day period after initial placement of the feeding tube</time_frame>
    <description>Occurence of nasal pressure ulcer (grade and location); sinusitis (running nose; nasal congestion); facial pain or pressure; dysosmia; frequent sneezing; epistaxis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain experienced from the nasal fixation</measure>
    <time_frame>During the 14-day period after initial placement of the feeding tube</time_frame>
    <description>Pain scored on a visual analogue scale (VAS) with a minimum score of 0 and a maximum score of 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discomfort experienced from the nasal fixation</measure>
    <time_frame>During the 14-day period after initial placement of the feeding tube</time_frame>
    <description>Discomfort scored on a visual analogue scale (VAS) with a minimum score of 0 and a maximum score of 100</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Feeding Tube Complication</condition>
  <condition>Feeding Disorders</condition>
  <arm_group>
    <arm_group_label>Nasal bridle</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nasal bridle fixation after nasoenteral feeding tube placement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal patch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nasal patch fixation after nasoenteral feeding tube placement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal bridle</intervention_name>
    <description>Bridle Pro® Nasal Tube Retaining System (Applied Medical Technology Inc., Brecksville, OH, USA)</description>
    <arm_group_label>Nasal bridle</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nasal patch</intervention_name>
    <description>Regular adhesive tape for medical use.</description>
    <arm_group_label>Nasal patch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patient (18 years or older)&#xD;
&#xD;
          -  received a nasoenteral feeding tube while being hospitalized&#xD;
&#xD;
          -  providing written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  contraindication for a nasal bridle (e.g., cleft lip or damaged nasal mucosa)&#xD;
&#xD;
          -  clinical need to place a nasal bridle&#xD;
&#xD;
          -  anticipated feeding nasoenteral feeding tube placement for &lt; 3 days&#xD;
&#xD;
          -  failure of nasoenteral feeding tube placement&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariël Klos</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gelre Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tjard Schermer, PhD</last_name>
    <phone>+31(0)655102377</phone>
    <email>t.schermer@gelre.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gelre Hospitals</name>
      <address>
        <city>Apeldoorn</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medisch Spectrum Twente</name>
      <address>
        <city>Enschede</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariël Klos</last_name>
      <phone>+31(0)640973307</phone>
      <email>mariel.klos@MST.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>January 12, 2023</study_first_submitted>
  <study_first_submitted_qc>January 12, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2023</study_first_posted>
  <last_update_submitted>January 20, 2023</last_update_submitted>
  <last_update_submitted_qc>January 20, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Feeding and Eating Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The IPD sharing plan has not been finished yet, scheduled for Q4 2023.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data are expected to become available in the course of 2024.</ipd_time_frame>
    <ipd_access_criteria>Will be defined as part of the IPD sharing plan, scheduled for Q4 2023.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

